Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a study

بواسطة Ali T. Taher, Zeynep Karakas, Elena Cassinerio, Noppadol Siritanaratkul, Antonis Kattamis, Aurelio Maggio, Stefano Rivella, Norbert Hollaender, Bruyere Mahuzier, Brian Gadbaw, Yesim Aydinok
منشور في 2019